Halma

Halma plc is a global group of life-saving technology companies.

Halma, a global provider of life-saving technology, publishes its scheduled trading update in advance of its half-year financial close on **30 September 2026**. The company operates across sectors including safety, clean energy, and healthcare, targeting a future where technology enhances daily well-being. This update precedes its formal reporting period, offering stakeholders preliminary insights into performance.

Sep 2026BOLSAMANIANews article

Halma acquires Pyxis, a U.S.-based water quality technology provider, for $170 million. The deal expands Halma’s portfolio in environmental monitoring solutions. Pyxis specializes in water quality instrumentation and analytics for industrial and municipal applications. Halma operates globally across safety, health, and environmental testing sectors.

Sep 2026Yahoo FinanceNews article

Halma sells its NovaBone subsidiary to Isto Biologics for **$60 million** in a cash deal. The transaction includes no debt obligations. The move follows Halma’s strategic shift toward core healthcare and safety technologies.

Aug 2026DirectorsTalk InterviewsNews article

Halma acquires Dreampath to integrate automated tissue sample traceability and storage into its Healthcare Sector. The move strengthens Halma’s capabilities in managing biological samples for research and diagnostics. Dreampath’s technology supports efficient tracking and preservation of tissue samples, enhancing workflows in healthcare and life sciences.

Jul 2026DirectorsTalk InterviewsNews article